netFormulary Buckinghamshire Formulary NHS
Buckinghamshire Healthcare NHS Trust
Buckinghamshire CCG

Welcome to the Buckinghamshire Formulary

Useful Links

Links for all users:
BHT Intranet Users Only:

Primary care Users

  • Primary care policies to support GPs

News Feed

September 19 - MHRA Drug Safety Update: Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping

September 19 - MHRA Drug Safety Update: Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication during pregnancy and in women of childbearing potential not using effective contraception

September 19 - MHRA Drug Safety Update: Elmiron (pentosan polysulfate sodium): rare risk of pigmentary maculopathy

September 19 - MHRA Drug Safety Update: Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions

August 19 - MHRA Drug Safety Update: Carfilzomib (Kyprolis▼): reminder of risk of potentially fatal cardiac events

August 19 - MHRA Drug Safety Update: Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive

>>> more news

The Buckinghamshire Formulary is a joint venture between Buckinghamshire Healthcare NHS Trust and Buckinghamshire CCG.  

All chapters of the Formulary are ready for use:

1.  Search for a drug or condition using the search box above.
2.  Non-formulary products are shaded in pink and labelled non-formulary.
3.  Formulary products may be found in one or more chapters.  Click on the entry in the appropriate chapter.
4.  Guidelines are linked at the top of each chapter or section, or within the individual product entry
5.  Traffic light classifications are displayed as a traffic light symbol
6.  Any comments/queries please email

Other Formulary Related Information:


IV Guide




NHS Clinical Knowledge Summaries

   Visits = 92375
   Last updated: 18/10/2019 16:59:09
    Download net formulary from Apple IOS Store  Google Play net formulary